drugset / Trial / NCT07122102
A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will compare the effect and safety of cofrogliptin (HSK7653) with acarbose among people with type 2 diabetes
Timeline
- Start
- 2025-10-01
- Primary completion
- 2027-06-30
- Completion
- 2027-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acarbose | Unknown | 50 mg | — |
| Subject | Cofrogliptin | Small molecule | 10 mg | — |